Physician profile
Amy Hill
NPI 1326403577
$992.14
in general payments reported to CMS, 2019-2025
12 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $129 · 2022: $191 · 2023: $254 · 2024: $244 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $244.83 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $189.26 | 2021-2024 | Farxiga |
| Silk Road Medical, INC. | $141.93 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Janssen Pharmaceuticals, INC | $85.92 | 2022-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $61.80 | 2022-2023 | Camzyos |
| Pfizer INC. | $54.05 | 2022-2025 | |
| Impulse Dynamics (USA) INC. | $52.48 | 2023 | Optimizer |
| Astellas Pharma US INC | $44.50 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.42 | 2025 | Lifevest |
| Boston Scientific Corporation | $30.15 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.30 | 2023-2025 | Jardiance |
| Amgen INC. | $15.50 | 2025 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.